Neurizon locks in global trademark protection across key pharma markets
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
The initiative is being led through the Bank’s CSR programme, Parivartan, in partnership with the Indian Cancer Society
The BEAR Implant is the first sports medicine device to carry a label claim related to lowering PTOA risk
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
The guidelines also support reusing tenofovir and abacavir in later regimens for improved outcomes, cost savings, and programmatic efficiency
Subscribe To Our Newsletter & Stay Updated